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Regeneration After Late Repair
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Objectives/Hypothesis: Facial nerve regenera-
tion is limited in some clinical situations: in long
grafts, by aged patients, and when the delay between
nerve lesion and repair is prolonged. This deficient
regeneration is due to the limited number of regener-
ating nerve fibers, their immaturity and the unre-
sponsiveness of Schwann cells after a long period of
denervation. This study proposes to apply glial cell
line-derived neurotrophic factor (GDNF) on facial
nerve grafts via nerve guidance channels to improve
the regeneration.
Methods: Two situations were evaluated: imme-
diate and delayed grafts (repair 7 months after the
lesion). Each group contained three subgroups: a)
graft without channel, b) graft with a channel with-
out neurotrophic factor; and c) graft with a GDNF-
releasing channel. A functional analysis was per-
formed with clinical observation of facial nerve func-
tion, and nerve conduction study at 6 weeks. Histo-
logical analysis was performed with the count of
number of myelinated fibers within the graft, and dis-
tally to the graft. Central evaluation was assessed
with Fluoro-Ruby retrograde labeling and Nissl
staining.
Results: This study showed that GDNF allowed
an increase in the number and the maturation of
nerve fibers, as well as the number of retrogradely la-
beled neurons in delayed anastomoses. On the con-
trary, after immediate repair, the regenerated nerves
in the presence of GDNF showed inferior results com-
pared to the other groups.
Conclusions: GDNF is a potent neurotrophic
factor to improve facial nerve regeneration in grafts
performed several months after the nerve lesion.
However, GDNF should not be used for immediate
repair, as it possibly inhibits the nerve regeneration.
Key Words: Glial cell line-derived neurotrophic




Facial nerve paralysis is a devastating clinical con-
dition leading to severe aesthetic and functional
alterations. When a surgical repair is indicated, the
appropriate technique is chosen according to the nature
and location of the lesion, the age of the patient, and the
delay between the nerve lesion and its repair. Although
direct end-to-end, tension-free coaptation is the most
effective procedure, a nerve gap often requires an
autologous nerve graft harvested on the sural or auricu-
lotemporal nerves.1 Nevertheless, poor functional results
are observed for mandibular or frontal branches graft-
ing,2–4 in the case of prolonged delay between the lesion
and the repair and by aged patients.5,6 The expected
reasons could be the limited number of regenerated
fibers or inefficacy of Schwann cells to support regenera-
tion in such clinical situations. Hypoglossal-facial
anastomosis is another effective technique when the
proximal facial nerve stump is not available for grafting
(after pontocerebellar angle tumor removal or centrally
occurring lesions).7 Nevertheless, results can be compro-
mised also in older patients or in case of prolonged delay
between the lesion and the repair. Cross-facial nerve
grafting has been described as an alternative to hypo-
glossal-facial anastomosis and consists in connecting
peripheral fibers of the facial nerve selected on the
healthy side to the lesioned side via an autologous nerve
graft.8 The results, however, have been disappointing
due to the insufficient number and the immaturity of
the regenerating nerve fibers, associated with the small
amount of fibers available in the donor site and the
length of the nerve gap.9 For these reasons, cross-facial
nerve grafting is nowadays only used in combination
with other techniques such as hypoglossal-facial
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anastomosis (babysitter procedure),10,11 or free muscle
transfer (m. gracilis, m. pectoralis minor, etc.).12
All surgical techniques described above have largely
contributed to reanimate a paralyzed face, yet with
inconsistent results related to the anatomical and indi-
vidual variability. In order to obtain more efficient nerve
regeneration, the next step is to target the nerve at a
molecular level. Indeed, neurotrophic factors delivered
through nerve guidance channels (NGCs) have been
demonstrated to be valuable tools for this purpose.
Neurotrophic factors are naturally occurring proteins
implicated in nervous system development, survival, and
repair.13 Among the different classes of neurotrophic fac-
tors, the glial cell line-derived neurotrophic factor
(GDNF), has been demonstrated to have potent regener-
ating effects on peripheral nerves.14–16 It increases the
number of regenerating nerve fibers, improves their ma-
turity and protects the neural cell bodies.14,17,18 This has
been demonstrated in the sciatic as well as in the facial
nerve, with GDNF delivered locally on the site of regen-
eration via nerve guidance channels during several
weeks.19,20 The aim of this study was to evaluate the
effect of GDNF locally delivered via a nerve guidance
channel on autologous nerve graft after immediate and
delayed repair of the mandibular branch of the rat facial
nerve.
MATERIALS AND METHODS
GDNF-Releasing Nerve Guidance Channels
NGCs were made of a nonresorbable ethylene vinyl ace-
tate (EVA) polymer tube, into the wall of which an EVA rod
releasing GDNF was incorporated as described previously.21,22
The recombinant neurotrophic factor GDNF was provided by
Amgen Inc. (Thousands Oak, CA). After implantation, the neu-
rotrophic factor was released progressively over several weeks.
In vitro GDNF release was evaluated using an ELISA assay as
described previously.19 The channels used in the present study
were taken from the same batches as those used earlier.19
Groups of Animals
Two main groups of 20 adult male Wistar rats each were
constituted. In the first group (immediate repair), the nerve
grafting procedure was performed immediately after the nerve
lesion. In the second group (delayed repair), the nerve repair
was achieved 7 months after the facial nerve lesion. Each group
was divided in three different subgroups: 1) autologous nerve
graft of 15 mm without channel, nor GDNF, n ¼ 4 (graft alone);
2) autologous nerve graft of 12 mm with a regular suture on
the proximal stump and a 5 mm channel without GDNF
between the distal nerve stump and the graft, separated by an
internal gap of 3 mm, n ¼ 6 (graft, channel without GDNF);
and 3) same as subgroup 2, but with a channel liberating
GDNF, n ¼ 10 (graft, channel GDNF).
Surgical Procedures
Adult male Wistar rats of approximately 300 g were anes-
thetized with isoflurane delivered with a Minerve anesthetic
apparatus. All animal protocols were approved by the local vet-
erinary commission in Lausanne, Switzerland, and carried out
in accordance with the European Community Council directive
86/609/ECC for the care and use of laboratory animals. Rats
were shaved in the facial area up to the shoulder, in the region
of sural nerve harvesting, on the dorsal face of the left leg.
Local disinfection was performed with a 25% Betadine/0.9%
NaCl solution. All surgical procedures were performed using a
surgical microscope (Zeiss, Oberkochen,Germany). For sural
nerve harvesting, the left leg was opened on the posterior side
with a longitudinal and medial incision. The sural nerve was
isolated, avoiding its compression and preserving the local vas-
culature. It was cut proximally and distally in order to obtain a
segment of at least 18 mm and prepared to obtain a unique fas-
cicule. For facial nerve repair, the skin was opened with a
preauricular and cervical incision on the left side. The mandibu-
lar branch of the facial nerve was exposed close to the
stylomastoid foramen and cut distally to the bifurcation in order
to preserve the zygomatic branch. A 10-mm segment of the
mandibular branch was removed before it gave rise to the mar-
ginal branches. This 10-mm gap was then replaced by a 15-mm
autologous nerve graft or a 12-mm nerve graft with a 5-mm
channel on the distal suture (internal gap of 3 mm) (Fig. 1A,
B). The whole system measured 15 mm in all animals, with or
without channel on the distal nerve stump. Each side of the
nerve was inserted 1 mm into the channel and fixed with one
10-0 trans-epineurial Ethilon suture (Ethicon/Johnson & Jonh-
son, Spreitenbach, Switzerland), leaving an internal nerve gap
of 3 mm (Fig. 1B). The proximal suture was fixed with three
11.0 nylon sutures. The channel was then fixed locally into the
masseter muscle with 3x 6-0 Prolene sutures (Ethicon/Johnson
& Jonhson, Spreitenbach, Switzerland) to reduce movements
due to scratching. Skin was closed with a nylon 5-0 Dermalon
(Sherwood-Davis & Geck, Adliswil, Switzerland). Animals were
housed during 6 weeks in a controlled environment with a 12
hour on-off light cycle and water and food ad libitum.
Fig. 1. (A) Photograph showing a 0.5-cm-long channel implanted
on the distal suture of an autologous nerve graft on the mandibu-
lar branch of the facial nerve. (B) Scheme of the system with a
5 mm channel on the distal suture. Each nerve stump is inserted
1 mm into the channel, creating a 3-mm internal gap.
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The animals included into the group of delayed repair
were first operated on the facial area. The facial nerve was sec-
tioned and a segment of 5 mm was removed. The two stumps
were ligatured in order to prevent a spontaneous regeneration.
After 7 months, the rats were reopened and the facial nerve
stumps were located. The two nerve stumps were recut in order
to remove the fibrous tissue and the same procedure was per-
formed as in the group with an immediate repair.
Functional Evaluation
Functional observation. The animals were examined to
evaluate the rapidity of nerve regeneration. The quality of con-
traction of the facial muscles (whiskerpads) was assessed and a
score was attributed to each animal, as described in the Table I.
The observations were performed at 3 and at 6 weeks after
nerve repair by two blinded observers.
Nerve conduction study. Nerve conduction (NC) studies
were performed 6 weeks after nerve repair (just after the sec-
ond clinical observation). The rats were maintained at a
constant temperature of 37C on a warming plate. In order to
prevent recording muscle contractions from the lateral whisker-
pad, the buccal branch of the facial nerve was sectioned just
prior to the study. Ground, recording, and stimulating monopo-
lar electrodes (Carbamed, Zurich, Switzerland) were inserted
subcutaneously. The active recording electrode was inserted at
the level of the chin, whereas the reference electrode was placed
in the interocular area. A ground electrode was inserted in the
front of the head. The stimulating electrodes were placed dis-
tally to the mandibular branch of the facial nerve. The
supramaximal compound muscle action potential (CMAP) was
recorded by progressive incremental stimulations and the nega-
tive area, expressed in msmV, was used for statistical analysis.
Retrograde Labeling
Four days before sacrifice, and immediately after NC stud-
ies, the animals were anesthetized as described under surgical
procedures, the operative site was reopened, and the facial
nerve was exposed and cut 8 mm distally to the channel, just
before it ramifies. Five microliters of a 5% Fluoro-ruby solution
(dextran, tetramethylrhodamine) (Molecular Probes, Life Tech-
nologies Corporation, Carlsbad, CA) in 0.9% NaCl were
delivered via a small cup fixed to the nerve with Histoacryl
glue (Braun, Sempach, Switzerland).
Channel and regenerated nerve retrieval. Six weeks
after surgery and 4 days after Fluoro-ruby delivery, the rats
were deeply anesthetized with a lethal intraperitoneal injection
of pentobarbital and perfused transcardially with 200 mL hep-
arinized PBS followed by 200 mL of 4% paraformaldehyde in
PBS pH 7.4. The operative site was reopened and the NGCs
and regenerated nerves (graft þ channel þ 5 mm beyond the
graft) were removed and postfixed for 15 days in PBS pH 7.4
containing 4% paraformaldehyde and 1% glutaraldehyde. The
brainstems were harvested, postfixed overnight in 4% parafor-
maldehyde in PBS pH 7.4 and submerged in a 25% sucrose
solution for 72 hours prior to cryosection.
Morphometric Analysis
The regenerated nerves were processed as described in a
former study.19 They were cut in the graft (in the middle of the
tube or 3 mm before the distal suture in the groups without
channel), and 4 mm distally to the channel. Myelinated axon
counts and morphometric analysis were performed under
microscopy at a magnification of 1,000 (objective 100 and
ocular 10). The maturation of the regenerated nerve fibers
was assessed by measuring the myelin thickness. The measure-
ments were performed randomly using an image analysis
system (analysis soft imaging system).
To assess the number of retrogradely labeled facial moto-
neurons, the brainstems were harvested, frozen on dry ice,
embedded in Tissue-Tek OCT compound (Miles, Streuli Rudolph
AG, Switzerland), and 20-lm sections were cut using a cryostat
Cryocut 1800 (Leica, Wetzlar, Germany). Retrogradely labeled
neurons were counted using an Olympus PX 40 fluorescence
microscope (Olympus, Center Valley, PA) with a wild-band UV
filter (200 magnification). The total number of labeled moto-
neurons in the facial nucleus was obtained by multiplying by 5
the number of neurons counted on every fifth section.
Neuronal survival. The total number of motoneurons
present in the facial nucleus was evaluated in Nissl-stained
sections. Only well-marked motoneurons with a clearly visible
nucleus and located in the facial nucleus area were counted in
every fifth section. The total number of counted motoneurons
was multiplied by 5 to obtain the total number of motoneurons
in the facial nucleus. The results were expressed as a percent of
motoneuron loss in the lesioned side compared to the unlesioned
side.
Statistical Analysis
All the data were analyzed for statistical significance
using a nonparametric analysis of variance (ANOVA) with a
Kruskall-Wallis test.
RESULTS
The results of the in vitro releases and bioactivity
assays performed with the nerve guidance channels con-
taining GDNF were reported in details in a previous
paper.19
Approximately 35% of all channels were found to be
disconnected at sacrifice, probably due to scratching (21
analyzable animals out of 32 implanted animals). The
animals with disconnected channels were not taken into
account for further analysis. Thus, only 4/6 animals in
the group, with channel without GDNF, and 8/10 ani-
mals in the group with channel with GDNF, could be
analyzed in the immediate repair group, whereas 5/6
animals in the group, with channel without GDNF, and
6/10 animals in the group with channel with GDNF,
could be analyzed in the delayed repair group.
TABLE I.
Quality of Contraction of Facial Muscles.
Score Observations
0 No function, asymmetry at rest
1 Symmetry at rest, but no voluntary movement
2 Symmetry at rest, weak voluntary contractions
3 Symmetry at rest, moderate voluntary contractions
4 Symmetry at rest, good voluntary contraction, but
persisting asymmetry in comparison with the
unlesioned side
5 Normal function, perfect symmetry compared to the
unlesioned side
All the animals were observed at 3 and 6 weeks. A score (0–6) was
attributed to each animal.
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Immediate Repair
As mentioned above, the subgroup with channel
without GDNF contained 4 analyzable animals (n ¼ 4),
and the GDNF subgroup contained 6 animals (n ¼ 6).
All animals of the normal graft subgroup were analyz-
able (n ¼ 4).
The observation of facial contractions at 3 weeks
gave similar scores in the different groups (no statistical
difference): a score of 2.5  0.3 points in the subgroup
with a normal graft, 3.0  0 points in the subgroup with
a distal channel delivering no neurotrophic factor, and
3.0  0.3 points in the subgroup with a graft with
GDNF releasing channels (Table II). Similarly, there
was no statistical difference between the different sub-
groups at 6 weeks. In the GDNF subgroup a score of 3.7
 0.4 was calculated, the normal graft subgroup gave a
mean score of 3.3  0.3, and the subgroup with channel
without neurotrophic factor had a score of 3.8  0.4
(Table II).
Considering the NC parameters, there was no sta-
tistical difference between the different groups. The
mean CMAP area was 2.4  0.46 mVms in the graft
alone subgroup, 1.69  0.58 mVms in the subgroup with
channel without neurotrophic factor, 3.05  0.84 mVms
in the subgroup with channel delivering GDNF, and 3.79
 0.12 mVms when recorded in the unlesioned side (Fig.
2A).
The pictures obtained in the group with immediate
repair are shown in the Figure 3B–D (in the graft) and
Figure 4A–C (distal to the graft). Myelinated axons were
found in each group. Nerves regenerated in normal con-
ditions of graft, without channel, showed 1,809  106
myelinated axons in the distal part of the graft, and
1,905  338 myelinated axons distally to the graft.
Grafts with a control channel allowed to obtain 2,042 
299 myelinated axons in the middle of the tube, and
2,008  522 myelinated axons distal to the graft. In the
grafts regenerated in the presence of GDNF, 3,268 
791 myelinated axons were counted in the middle of the
channel and 1,077  248 distally to the graft. There was
no statistical difference between the GDNF subgroup
and other subgroups. As a comparison, a naive nerve
contains 1,404  36 axons. Similarly, there was no sta-
tistical difference between the different repaired groups
when measuring the myelin thickness.
The pictures of retrogradely labeled motoneurons of
the facial nucleus are shown in Figure 5A–D. The retro-
grade labeling performed on the control side showed a
total number of 2,207  95 labeled neurons. In this
group, the number of retrogradely labeled neurons is sig-
nificantly lower in the GDNF subgroup (1,059  73) than
in the graft alone subgroup (1,739  86) (P < .01) and
lower than in the subgroup with channel without GDNF
(1,489  114) (P < .03). Similarly, neuronal loss on the
lesioned side, compared to the unlesioned side, was sig-
nificantly higher in the GDNF subgroup (16.4  2% of
difference) than in the other groups (10.9  1.7% in the
subgroup channel without GDNF, P < .001; and 1.1 
0.6% in the graft alone subgroup, P < .001) (Fig. 6A).
DELAYED REPAIR
In the group of delayed repair, all the repaired ani-
mals of the normal graft subgroup were analyzable (n ¼
4), although one rat in the subgroup channel without
GDNF and five rats of the GDNF subgroup had to be
discarded because of channel disconnection. Thus, the
subgroup channel without GDNF contained five analyz-
able animals (n ¼ 5), and the GDNF subgroup contained
5 animals also (n ¼ 5).
The observation of facial contractions at 3 weeks
gave a score of 1  0 point in the subgroup with a nor-
mal graft, 1.2  0.2 point in the subgroup with a distal
channel delivering no neurotrophic factor, and 2.3  0.3
points in the subgroup with a graft with GDNF
TABLE II.
Facial Contractions: Immediate Repair Group.
Score at 3 wk Score at 6 wk
Graft without channel 2.5  0.3 3.3  0.3
Graft and channel without GDNF 3.0 3.8  0.4
Graft and channel with GDNF 3.0  0.3 3.7  0.4
GDNF ¼ glial cell line–derived neurotrophic factor.
No statistical difference was found between the different subgroups
at 3 and 6 weeks.
Fig. 2. Electromyogram measured at 6 months, just before nerve
transection for retrograde labelling. (A) Immediate repair group; no
statistical difference was found between the different repaired
groups. (B) Delayed repair group; the surface measured under the
curve was significantly larger in the GDNF subgroup compared o
the other repaired groups (P < .02 when comparing the GDNF
subgroup with the normal graft subgroup, and P < .03 when com-
paring the GDNF subgroup with the subgroup channel without
GDNF).
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releasing channels, respectively (Table III). The differ-
ence between the GDNF subgroup and the two other
subgroups was significant (P < .01, GDNF compared
with normal graft; and P < .02, GDNF compared with
channel without GDNF). At 6 weeks, the differences
between the different subgroups were not as pronounced
as at 3 weeks, but a tendency for a better function in
the GDNF subgroup was observed, with a score of 4.3 
Fig. 3. Photomicrographs of facial nerves regenerated in the distal part of the graft. (A) Represents a normal naive mandibular branch of
the facial nerve. (B–D) Immediate repair. (B) Graft alone, section 3 mm from the distal suture; (C) Graft with channel delivering GDNF; (D)
Channel without GDNF. Original magnification, 1,000; scale bars ¼ 20 lm. The total number of myelinated fibers has been evaluated for
each group. Statistical significance was evaluated using the nonparametric Kruskall-Wallis test. No statistical significance has been found
between the different repaired groups. (E–G) Delayed repair. (E) Normal graft; (F) Graft with channel delivering GDNF; (G) Channel without
GDNF. Original magnification, 1,000; scale bars ¼ 20 lm. The total number of myelinated fibers has been evaluated for each group.
Statistical significance was evaluated using the nonparametric Kruskall-Wallis test. The subgroup with GDNF-delivering channels showed
a significantly larger number of myelinated nerve fibers than the normal graft subgroup and the subgroup with channel delivering no GDNF
(P < .03 and P < .01, respectively).
Fig. 4. Photomicrographs of facial nerve regenerated 4 mm distally to the graft. (A–C) Immediate repair. (A) Graft alone; (B) Graft with chan-
nel delivering GDNF; (C) Channel without GDNF. The total number of myelinated fibers has been evaluated for each group. Statistical signif-
icance was evaluated using the nonparametric Kruskall-Wallis test. No statistical significance has been found between the different
repaired groups. (D–F) Delayed repair. (D) Graft alone; (E) Graft with channel delivering GDNF; (F) Channel without GDNF. Original magnifi-
cation, 1,000; scale bars ¼ 20 lm. The total number of myelinated fibers has been evaluated for each group. Statistical significance was
evaluated using the nonparametric Kruskall-Wallis test. The subgroup with GDNF-delivering channels showed a significantly larger number
of myelinated nerve fibers than the normal graft subgroup and the subgroup with channel delivering no GDNF (P < .03 and P < .02,
respectively).
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0.3, whereas the graft alone subgroup gave a mean score
of 3.3  0.3, and the subgroup channel without GDNF
had a score of 3  0.3 (Table III).
Considering the NC parameters, the CMAP area
was significantly larger in the GDNF subgroup (1.34 
0.21 mVms), whereas it measured 0.42  0.15 mVms in
the group with a graft alone (P < .02), 0.43  0.24
mVms in the subgroup with channel without GDNF (P
< .03), and 3.79  0.12 mVms in the unlesioned side
(Fig. 2B).
The pictures obtained in the group with delayed
repair are shown in the Figure 3E–G (distal part of the
graft) and Figure 4D–F (distally to the graft). Myelin-
ated axons were found in each subgroup. Nerves
regenerated in normal conditions of graft, without chan-
nel showed 1,185  101 myelinated axons in the distal
part of the graft, and 655  130 myelinated axons dis-
tally to the graft. Grafts with a channel without GDNF
resulted in 335  113 myelinated axons in the distal
part of the graft (middle of the channel), and 214  114
myelinated axons distally to the graft. In the grafts
regenerated in presence of a GDNF delivering channel,
the number of myelinated axons was larger at the two
sites of analysis: 3,204  747 myelinated axons in the
distal part of the graft (middle of the channel), and
1,608  363 myelinated axons distally to the graft. As a
comparison, a naive nerve contains 1,286  43 axons.
When analyzing the different subgroups for significance,
the GDNF subgroup showed a significantly larger num-
ber of myelinated fibers into the graft than the normal
graft subgroup (P < .03), as well as the channel without
GDNF subgroup (P < .01). Similarly, the GDNF
subgroup showed a significantly larger number of
myelinated fibers distally to the graft than the normal
Fig. 5. Retrograde tracing of facial motoneurons. Micro-
graphs showing Fluororuby-labeled motoneurons in the fa-
cial nucleus. (A–D) Immediate repair group; (A) Retrograde
tracing performed in an unlesioned rat; (B) Graft alone; (C)
Graft, channel GDNF; and (D) Graft, channel without
GDNF. Original magnification, 100; scale bars ¼ 200 lm.
The quantification of Fluororuby retrogradely labeled
motoneurons into the facial nucleus showed a significantly
larger number of labeled neurons in the subgroup with
normal graft, as well as the subgroup of graft, channel
without GDNF compared to the subgroup with graft and
channel delivering GDNF (P < .01, and P < .03, respec-
tively). (E–H) Delayed repair group; (E) Retrograde tracing
performed in an unlesioned rat; (F) Graft alone; (G) Graft,
channel GDNF; and (H) Graft, channel without GDNF. Orig-
inal magnification, 100; scale bars ¼ 200 lm. The num-
ber of retrogradely labeled motoneurons was significantly
larger in the group of graft with GDNF compared to normal
graft (P < .03) and compared to the group graft and chan-
nel without GDNF (P < .01).
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graft subgroups and the channel without GDNF sub-
group (P < .03 and P < .02, respectively).
The myelin thickness was assessed as a measure of
maturation of the regenerated fibers. This measure was
performed in the distal part of the graft and distally to
the graft. In all cases, the myelin thickness of the regen-
erated axons was smaller than that of a naive nerve
(0.98  0.01 lm) (Fig. 7). In the distal part of the graft,
myelin thickness was larger in the graft alone subgroup
(0.41  0.01 lm) than in the two other groups (0.28 
0.01 and 0.35  0.02 lm in the subgroup with channel
without neurotrophic factor and GDNF channel, P < .05,
respectively). However, distally to the graft, the myelin
thickness became significantly larger in the presence of
GDNF (0.34  0.01 lm) than in the groups without neu-
rotrophic factor (0.3  0.01, P < .03; and 0.27  0.01, P
< .02 lm in the graft alone and channel without GDNF,
respectively).
Micrographs of retrogradely labeled motoneurons in
the facial nucleus are shown in Figure 5E-H. The counts
of retrogradely labeled motoneurons in the facial nucleus
revealed a total number of 1,516  98 motoneurons in
the unlesioned animals. In the presence of GDNF, 1,051
 200 retrogradely labeled neurons were counted,
whereas only 410  142 and 257  101 labeled neurons
were present in the graft alone subgroup and in the
channel without GDNF subgroup, respectively.
The neuronal loss on the lesioned side compared to
the unlesioned side showed very little difference in the
subgroup with GDNF (0.5  1.1%), whereas the differ-
ence was much larger in the other groups (13.6  1.0%
in the channel without GDNF subgroup, and 9.6  1.7%
in the graft alone subgroup) (Fig. 6B). These differences
were statistically significant, P < .009, when comparing
the subgroup with the subgroup graft alone, and P <
.001, when comparing the subgroup channel delivering
GDNF with the subgroup channel without GDNF.
Fig. 6. Motoneuron loss on the lesioned side was expressed as a percentage of the unlesioned side. (A) Immediate repair group; the neuro-
nal loss was significantly larger in the channel GDNF group than in the two other groups (P < .001 for both); (B) Delayed repair group; the
neuronal loss was significantly lessened in the channel GDNF group than in the subgroup with graft alone and the subgroup channel deliv-
ering no GDNF (P < .009 and P < .001, respectively).
TABLE III.
Facial Contractions: Delayed Repair Group.
Score at 3 wk Score at 6 wk
Graft without channel 1 3.3  0.3
Graft and channel without GDNF 1.2  0.2 3  0.3
Graft and channel with GDNF 2.3  0.3 4.3  0.3
GDNF ¼ glial cell line–derived neurotrophic factor.
At 3 weeks, the score obtained in the GDNF subgroup was signifi-
cantly better than in the normal graft subgroup and in the graft with chan-
nel without GDNF subgroup (P < .01 and P < .02, respectively). No
statistical difference was found between the different subgroups at 6
weeks.
Fig. 7. Quantification of myelin thickness as a measure of maturity
of regenerated nerves in the delayed repair group. (A) In the distal
part of the graft; the myelin thickness was significantly larger in
the normal graft group compared to graft with channel GDNF (P
< .05); (B) 5 mm distally to the graft; the myelin thickness was
significantly larger in the subgroup of graft with GDNF compared
with normal graft subgroup (P < .03) as well as the channel with-
out GDNF subgroup (P < .02).
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DISCUSSION
Recovery after facial nerve injury is often poor de-
spite the various grafting techniques applied in the
clinic. This is the case particularly in lesions of the man-
dibular or frontal branches, when cross-facial nerve
grafts have to be performed in aged patients and when
the delay between the lesion and its repair is pro-
longed.3,5,23,26 So far, facial nerve regeneration with local
application of nerve growth factor or brain derived
neurotrophic factor, two neurotrophic factors of the
neurotrophin family, had revealed only limited improve-
ment.27,28 Our previous study demonstrated that GDNF
is a potent neurotrophic factor, which improves facial
nerve regeneration in the peripheral nervous system,
and promotes survival in the central nervous system.19
However, this study was not designed for clinical pur-
poses, but to identify the most potent neurotrophic
factor for facial nerve regeneration. The present study
focused on a more clinical model, consisting in improving
facial nerve regeneration with the local application of
GDNF on the distal sutures of autologous nerve grafts
performed on the mandibular branch of the facial nerve.
The distal placement of the channel was determined
according to the literature.29 Indeed, in cases of silicone
channels delivering no neurotrophic factors, it has been
determined that the distal placement of a channel had
better effects than its proximal or both-sites place-
ments.29 Different studies allowed to fix the ideal
internal gap to 3–4 mm.30–34 Similarly, it has already
been determined that an entubulated end-to-end coapta-
tion has no effect on nerve regeneration.35
Continuous release of nanogram quantities of
GDNF on the distal suture of autologous nerve grafts
over a period of 6 weeks gave opposite results in the two
groups of the study, i.e., immediate or 7-month delayed
repair. In the immediate repair group, no, and even a
tendency of worse results, were obtained with GDNF.
On the contrary, a delayed repair allowed for much bet-
ter results in the presence of GDNF.
In the immediate repair group, the subgroup with
GDNF showed significantly fewer regenerated nerve
fibres in the distal nerve stump (distally to the channel),
no improved maturation, a significantly lower number of
retrogradely labeled motoneurons in the facial nucleus,
as well as a larger percent of motoneuron loss on the
lesioned side. It has previously been shown that a periph-
eral nerve crush leads to a rapid up-regulation of the
GDNF mRNA in the distal nerve stump, an increase of
GDNFR-alpha receptor in the distal nerve stump, and
an up-regulation of the Ret mRNA in the motor neu-
rons.18,36,37 A facial nerve lesion induces an up-
regulation of the mRNAs of the GDNFR-alpha-, c-ret-,
and vesicle-associated membrane proteins receptors in
the facial motor neurons.17,38 However, unpublished
results obtained in our previous studies allowed us to es-
tablish that large amounts of GDNF delivered at the
lesion site had deleterious effects, with even an inhibition
of nerve regeneration in cases of overdose. The lessened
regeneration obtained in cases of immediate repair with
the addition of exogenous GDNF could be due to a too
large amount of neurotrophic factor GDNF. Indeed, exog-
enous GDNF added to the in vivo delivered GDNF could
produce an excessive dose of neurotrophic factor, thus
leading to deleterious effects on nerve regeneration.
On the contrary, when the delay between the lesion
and its repair is prolonged, the application of GDNF to a
chronically denervated nerve gave significantly better
results than repairs without neurotrophic factor (graft-
alone subgroup and graft with a channel without GDNF
subgroup). In this situation, functional results and the
CMAP areas measured at EMG were significantly better
for the GDNF subgroup. The number of regenerated
myelinated nerve fibers and the maturity of the regener-
ated fibers were also significantly better in the GDNF
subgroup. Similarly, the central patterns were signifi-
cantly better in the nerve regenerated in the presence of
GDNF (significantly larger number of retrogradely
labeled motoneurons and significantly less neuronal
loss when comparing the lesioned versus the unlesioned
facial nuclei). In this situation, the exogenous supply of
GDNF allowed significantly improved facial nerve
regeneration. It has been demonstrated that in cases of
prolonged denervation, the Schwann cells of the distal
nerve stump are no more responsive to a front of
regenerating nerve fibers and are no more able to pro-
duce proregenerating substances, such as GDNF, and
become unable to maintain important trophic support
for both motor and sensory neurons.37–39 This phenom-
enon exists even if a fresh graft is interposed between
the proximal and distal nerve stump. As a consequence,
the regenerating nerve fibers decrease in quantity and
are much less myelinated.6 Thus, the exogenous supply
of trophic substances improves the ability of Schwann
cells to play their role, which improves the peripheral
nerve regeneration in the chronically denervated distal
nerve stump.40 This phenomenon is confirmed by the
maximum changes of histological pattern in the distal
nerve stump and the larger number of retrogradely la-
beled motoneuron in the facial nucleus in the GDNF
channel subgroup.
The animals of the delayed graft group could also
be considered as aged animals compared to the immedi-
ate repair group. This was confirmed by the histological
results obtained in the two different groups. The retro-
grade labeling showed a significantly larger number of
labelled neurons in the unlesioned facial nucleus in the
immediate group (1,516  98 labelled neurons) than in
the delayed group (2,207 95 labeled motoneurons, P <
.0003), due to the older age of the animals in the delayed
group. The labeled neurons showed also less fluorescein
in the immediate repair group than in the delayed
repair group. Similarly, the number of myelinated axons
was significantly larger in the unlesioned mandibular
branch in the immediate repair group (1,404  36 my-
elinated fibers) than in the delayed group (1,286  43
myelinated fibers, P < .05). The GDNF could also have
had a second effect in the delayed repair group by sup-
porting the senescent Schwann cells, known to be less
effective in the elderly [5, 41].
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CONCLUSION
In summary, GDNF is a potent molecule for promot-
ing facial nerve regeneration after autologous nerve
grafts in situations where the delay between the nerve
injury and its repair is prolonged and by aged patients.
On the contrary, GDNF should not be used in cases of
immediate repair, as it seems to produce deleterious
effects on peripheral nerve regeneration. The application
of GDNF in the clinic to autologous nerve grafts could
thus be limited to situations where the nerve graft is
long (proximal lesions, cross-facial nerve grafting), and
in cases of aged patients.
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